To evaluate different aspects of obesity, such as body fat distribution, plasma hormone and lipid pro®les, adipose tissue composition and dietary intake in an obese population in order to identify the most important factors that contribute to obesity. DESIGN: Eighty-®ve obese subjects, 30 men and 55 women (age, 30 ± 70 y; body mass index (BMI), 27 ± 35 kgam 2 ), were studied using anthropometric measurements, computed tomography, adipose tissue composition, serum hormone and lipid pro®les and nutritional evaluations. To determine to what extent individual factors contributed to the general process of obesity, the data were subjected to a factor analysis. RESULTS: Three patterns of anthropometric and computed tomography data emerged that accounted for 69% of the variance. Factor 1 de®ned abdominal obesity and explained 30% of the total variance, factor 2 (gynoid obesity) accounted for 26%; and factor 3 (subcutaneous fat) explained 13% of the total variance. When other factors associated with obesity, such as lipid pro®le, hormonal pro®le and fat composition, were introduced, obesity itself, especially abdominal obesity, remained the principal factor, accounting for 23% of total variability. All factors were of secondary importance when dietary characteristics were introduced. In the overall factor analysis, more than 40% of the variability in obesity was related to dietary habits, particularly fat intake, followed by energy and saturated fatty acids intake. CONCLUSION: Even though obesity is a multifactorial phenomenon, the results suggest that dietary intake, especially fat intake, is the most important factor contributing to obesity. Secondary factors include endocrine and metabolic factors.
Introduction
Classically, adipose tissue has been regarded as an energy store, although, nowadays, its role as a regulator of different metabolic aspects of our organism has taken on similar importance. Physiologically and pathophysiologically, adipose tissue is involved in a series of processes such as changes in body composition and the modi®cation of hormonal actions and biochemical processes. Perhaps the clearest example today is what Reaven described as the`X syndrome', more commonly referred to as the Metabolic Syndrome. 1 Its relationship with obesity stems from the percentage of total fat and its distribution, and it has been reported by various authors that abdominal and especially perivisceral adipose tissue is mainly responsible for the alterations associated with this syndrome. 2 Adipose tissue as a store of energy in the form of triglycerides may behave differently in different locations when considered from a hormonal or biochemical point of view, 3 or when fatty acid composition is studied. 4 The action of sex hormones on adipose tissue has become a topic of special interest today. Some of these hormones, such as dehydroepiandrosterone sulfate (DHEA-S), are possible therapeutic factors in obesity. 5 Similarly, it has been known for some years that adipose tissue is able to produce substances whose action is similar to that of classical hormones. These act not only at a distance on target organs such as the hypothalamus, but also in a paracrine and autocrine way. Nowadays, leptin and tumor necrosis factor a (TNF-a) are the reference points for the understanding of certain adipose behavior with respect to different types of obesity and their related pathologies. 6 When discussing the accumulation of fat in the adipose tissue as being the consequence of a positive energy balance, it is necessary to re¯ect on the dietary habits of the obese population. Metabolic variations associated with obesity and alterations in dietary intake may also have an in¯uence on the lipid pro®le and cardiovascular risk of the subject. 7 All these factors, and others, play a role in obesity and determine to a greater or lesser extent this pathology. For this reason obesity is classically known as a multifactorial disease. Even so, studies including metabolic, endocrine and nutritional factors in obese populations are scarce.
The purpose of this study was to evaluate different aspects of obesity, such as body fat distribution, the plasma pro®le of different hormones, modulator substances (leptin, TNF-a, etc.), serum lipid metabolism, adipose tissue fatty acid composition and dietary intake in an obese population, to ascertain which factors are subjected to varimax rotation, and to assess the biological signi®cance of the results obtained, ie which factors contribute most to obesity.
Methods

Subjects
Eighty-®ve patients between 30 and 70 y of age, including 30 men, 21 premenopausal women and 34 postmenopausal women, were selected from the outpatient clinics of the University`Virgen de la Arrixaca', the General University and the`Morales Meseguer' Hospitals, in Murcia, Spain. All the patients were obese, grades I and II (BMI 27 ± 35 kgam 2 ) and were being admitted for abdominal surgery or laparoscopy for reasons that did not interfere in the study: gallbladder, ulcer or umbilical hernia. Patients who were on a special diet, who were under treatment with calorigenic, lipogenic or contraceptive drugs, those affected by any endocrinological alteration or who had been diagnosed as having chronic renal failure, chronic hepatopathy or cancer, were excluded from the study. All patients gave their informed consent to participate in the study, which was approved by the Ethics Committee of the Arrixaca Hospital.
Analysis and techniques
All patients participating in the study were submitted to anthropometric measurements to evaluate the degree and type of obesity. Weight was determined in subjects wearing light clothes and bare-footed, using a digital electronic weighing scale. Height was determined using a Harpenden digital stadiometer (range 0.7 ± 2.05 m), with the subject upright and the head in the Frankfurt plane. Total body fat (%) was derived by using Siri's equation 8 and was based on body density as determined from the following skinfolds: biceps, triceps, suprailiac and subscapular. All measurements were obtained on the right side, with the subject in an upright and relaxed position. Measurements were taken 1 cm from the position of the ®ngers and perpendicular to the anatomic region. A Harpenden skinfold caliper (Holtain Ltd, Pembrokeshire) with a constant pressure of 10 gamm 2 in any position was used to carry out the measurements. Body fat distribution was assessed using different circumferences: waist 1 (W1), midway between lower rib margin and iliac crest; waist 2 (W2), at the level of the iliac crest, passing through the umbilicus; hip, the widest circumference over great trocanthers; and oblique thigh. All these measurements were made three times by a single operator. Computed tomography (CT) was used to assess the intra-abdominal distribution of fat. Measurements of visceral and subcutaneous adipose tissue areas were performed using a TOSHIBA CBTB007A Scanner (Toshiba Corporation, Otowawara). 9 A single 10 mm scan at L4 ± L5 level was performed with a 512 Â512 matrix, a window size of 300 Houns®eld units (HU) and a center of 40 HU. The subcutaneous (SA) and visceral abdominal fat areas (VA) were determined from a tomodiagram section by image analysis using a MIP-Microm Image Processing System (Microm, Barcelona, Espan Äa) based on the BMIO 10 (Kontron Eching, Germany). After evaluation of both areas, the VAaSA index was calculated. Sagittal and coronal diameter were determined directly in the computed tomography scan.
10 Blood samples were collected after an overnight fast the day before surgery. Serum was separated after centrifugation and stored at À20 C until analysis. Insulin, TNF-a and sex hormone binding globulin (SHBG) were determined by IRMA with reagents from, Biosource (Fleurus, Belgium), Medgenix Diagnostics (Fleurus, Belgium) and Orion Diagnostica (Espoo, Finland), respectively. 17b-Estradiol and testosterone were determined by ELISAacompetition with biotineaestreptavidine technology with reagents purchased from Boehringer Mannheim Immunodiagnostics (Meylan, France). Androstenedione, leptin, peptide C and DHEA-S were determined by RIA with reagents purchased, respectively, from Immunonotech (Marseille, France), Linco Research (St Charles, MO, USA), Byk-Santeg Diagnostica, DSL (von Hevesy-Strasse, Dietzenbag) and Diagnostic Systems Laboratories Inc. (Webster, TX, USA). Plasma lipids (triglycerides, total cholesterol, high-density lipoprotein (HDL-C) cholesterol, low-density lipoprotein (LDL-C) cholesterol, and apolipoproteins A and B (Apo A and B)) were also determined. To evaluate dietary intake, patients computed a 7 day dietary record. 11 Abdominal adipose tissue samples were obtained during surgery and fatty acid composition from subcutaneous and visceral fat was analyzed by means of gas chromatography. 12 A full listing of total variables measured is shown in Appendix 1.
Statistical analysis
In order to determine whether all these variables could be replaced by a smaller number of underlying patterns or factors and how they contributed to explaining the general Fat intake is the main factor in obesity M Garaulet et al process of obesity, data were subjected to factor analysis with the BMDP4M statistical software. 13 This methodology determines whether the different aspects analyzed can be replaced by a smaller number of underlying patterns or factors to reduce the variance in the data matrix of the entire population. A factor with a high eigenvalue is one that can be held accountable for a signi®cant amount of variance. Factor analysis searches for patterns, or factors, that have eigenvalues greater than one. For this analysis an orthogonal rotation method was used. Gamma is pre-assigned to 1 because varimax rotation was performed. Rotated factor loadings (pattern) are coef®cients of the factor after rotation and show the degree to which a given variable is represented in a particular factor. The cutoff value used to assess relevance of loadings was 0.25. Factor analysis was applied into four different steps to avoid possible confusion that could arise from including so many variables at once.
Step 1 introduced the anthropometric and CT characteristics, which de®ned obesity type and degree. In step 2 hormones and intermediate metabolites were introduced. Serum lipids were included in step 3. Finally, dietary intake and fatty acids, not only those originating from the diet but also from the different regions of adipose tissue, were included (step 4). Since all the variables introduced were affected by biological and measurements in¯uences, a Gaussian distribution was assumed. Tables 1 ± 4 contain mean values ( AE s.d.) describing the men, postmenopausal and premenopausal women and the total population. Table 1 gives the anthropometric and CT variables. Hormone and lipid pro®les are shown in Table 2 and dietary intake and fatty acids composition are presented in Tables 3 and 4 Factor analysis of determinants of obesity To assess the biological signi®cance of the results obtained, it is crucial to explain the different steps followed during the entire process.
Results
General characteristics
Step 1. In this factor analysis, the variables de®ning obesity and body fat distribution were introduced ®rst (Table 5) . Three patterns of anthropometric and CT data emerged that accounted for 69% of the variance. Thus, different combinations of these factors (labeled F1, F2 and F3) could regenerate 69% of the total information in the`degree of obesity and body fat distribution' data. The rotated factor-loading pattern for the three principal factors is shown in Table 5 . F1 explained 30% of the total variance, and loaded highest and positively by waist, sagittal diameter, visceral area, Step 2. When other factors associated with obesity and adipose tissue, such as serum hormonal pro®le, were introduced, obesity itself, especially abdominal obesity, was still the main factor (F1), accounting for 23% of total variance, followed by gynoid obesity (F2) and subcutaneous fat (F3) ( Table 6 ). These results concurred with step 1, but all the factors together explained only 53% of the total variance, as opposed to 69% in step 1. It seems important to highlight that in F1, among abdominal obesity variables, SHBG is also present, loading negatively by À0.68. On the other hand, F3, loaded mainly by the different skinfolds, also includes testosterone, loading 0.55. F4, F5 and F6 were all composed of different groups of hormones, and they explained 21% of the total variance. Taking into account the biological signi®-cance, F5, loaded mainly by androstenedione, DHEA-S and leptin, could be considered as a`metabolic factor of obesity', while F6, loaded highly and positively by insulin, C peptide and TNF-a, could be interpreted as a`hyperinsulinism factor'. Although there was no biological meaning established for F4, this factor seems to include those variables that are highly dependent on gender and age.
Step 3. When the serum lipid pro®le was included in the analysis (Table 7) , F1 was still abdominal obesity, which explained 23% of total variability, while F2 was what we have already de®ned as the`metabolic factor of obesity'. It is only after introduction of anthropometric and hormonal variables that lipids appeared in this analysis (F4 and F5). These ®ve factors together explained 69% of the total variance. No biological meaning could be established for F3.
Step 4. All the factors, including abdominal obesity, were relegated to a second level when dietary characteristics were introduced into the factor analysis (Table 8) . Dietary intake (F1 and F2) explained 41% of total variance, while abdominal obesity accounted for 12% (F3). In the fourth position appeared plasma lipids (F4). The results show that F1 was loaded highly by fat intake, followed by energy and saturated fatty acids. In the same way, the importance of fatty acid composition of body fat (F6) remains less important than dietary factors. No biological meaning could be established for F5.
Discussion
General characteristics
The criteria for selecting patients were veri®ed by anthropometric parameters. BMI was above 30 kgam 2 , and the tricipital, abdominal, subscapular and suprailiac skinfolds of the population were clearly within the`obese' range when Loadings less than 0.25 not recorded.
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14 Data obtained from CT analysis showed that the population had a visceral type obesity with a relationship between visceral and subcutaneous abdominal fat areas (VAaSA) greater than 0.4. 15 Premenopausal women scored lowest for most abdominal distribution fat parameters (Table 1) .
Of the set of sex hormones that were studied (Table 2) , only DHEA-S showed values below normal in the three groups studied, which is comparable to other studies in obese populations. 16 This hormone has been accredited with an anti-obesity action as well as a protective role against associated metabolic problems. 17, 18 The ®ndings that TNF-a values in the obese population were above the normal range coincides with various studies which indicate that the synthesis and secretion of this cytokine increases with obesity 19, 20 and can be interpreted as an adaptation mechanism for the prevention of future weight gain. 21 Serum leptin values were far above normal ranges in both sexes, con®rming the results of other authors, which indicate that obese individuals have a mean leptin concentration in serum approximately four times higher than individuals of normal weight. 22 Levels of triglycerides, although within the range of normality, were higher than those obtained for the total population in our region, while HDL-C values were lower (Table 2) . 23 All these data agree with the characteristics of dyslipidemia due to hyperinsulinism, initially described as hypertriglyceridemia associated with a reduction in HDL-C. 24 The dietary intake of the population studied appeared to be unbalanced: fat intake was far higher than recommendations and carbohydrate intake far lower (Table 3) . 25 These results are repeated constantly in nutritional evaluations of obese populations. 26 ± 28 The results showed an adequate distribution of SFA, MUFA and PUFA, contrary to the ®nd-ings obtained by other authors, 29 re¯ecting the fact that the patients studied are from a typical Mediterranean area where olive oil is the main dietary source of fat. 30 
Factor analysis
The results obtained by submitting all the data to factor analysis show that in steps 1, 2 and 3`abdominal obesity' is the most important factor. This factor is loaded mainly by ®ve variables, waist 1 and 2, sagittal diameter, visceral area and gender (Table 5 ). It is known that the best method to measure a central fat pattern is to determine visceral area by CT. Even so, sagittal diameter has been considered as the best predictor of intraabdominal fat. 31, 32 The simplest method is to measure the abdominal circumference at the halfway point between the lower rib and the iliac crest (waist 1), or at the umbilicus level (waist 2). 33 These measurements correlate highly with visceral fat content. 34 It is also well recognized that there are sex differences in body fat distribution, men being prone to accumulate upper body and abdominal fat, whereas women generally present a pattern of gluteofemoral deposition. 10 It is therefore not surprising that these ®ve variables, waist 1 and 2, sagittal diameter, VA and gender, are situated in the same factor, denominated thè abdominal obesity factor'. Taking into account the fact that this factor appeared in ®rst place when obesity degree and type, serum hormones and lipid pro®le were included, explaining 30, 23 and 23% of the total variance respectively, it can be considered that intra-abdominal fat is the factor that best explains the obesity of our patients and that, as a consequence, metabolic and hormonal changes take place. Other authors have also indicated that it is not only the excess of adipose tissue, but also its distribution, which are important in pathologies associated with obesity. 35 When the different steps are studied in more detail, we observe that, with the introduction of the hormone pro®le analysis, the`abdominal obesity factor' includes SHBG (Table  6 ). This transporter globulin appears to be associated not only with obesity but also with abdominal distribution: 36 as obesity and the accumulation of abdominal fat increase, its Fat intake is the main factor in obesity M Garaulet et al plasma values decrease, and this decrease is related in turn to pathologies associated with obesity. Testosterone is the ®rst hormone to appear in the analysis, in the factor named`subcutaneous fat' (Table 6 ). It is associated with body fat, and affects lipogenesis and lipolysis via androgenic receptors that, together with growth hormone, inhibit the action of lipoproteinlipase enzyme. 37 Insulin appears after abdominal, gynoid and subcutaneous obesity factors, and after 17b-estradiol and testosterone, and the factor known as`metabolic factor of obesity' which includes DHEA-S, leptin and androstenedione (Table 6 ). TNF-a is located in the same factor as insulin and C peptide. Recent studies indicate that this cytokine is involved in the insulin resistance associated with obesity. 38, 39 Gender, which appeared in ®rst place in the ®rst step, included in the abdominal obesity factor, is now located in sixth position, indicating that when other factors besides abdominal fat variables are introduced it loses relevance. The fact that it is now with leptin and 17b-estradiol is easy to understand if we take into account the fact that plasma values of both hormones differ signi®cantly between sexes, being much higher among women (Table 2) .
When serum lipids are introduced into the analysis, they appear in fourth and ®fth position (Table 7) . Obesity and thè abdominal obesity factor' are still the principal factors explaining the variability of our patients. The fact that the lipid pro®le is placed below the hormonal factor seems to indicate that obesity per se and abdominal fat distribution may induce hormonal changes and that these two factors combine to favor metabolic variations in plasma lipids. These results suggest, as do those of other authors, that fat distribution 40 and hormonal serum pro®le 41 may condition alterations in lipid metabolism in an obese population.
When patients' dietary intake is introduced, abdominal obesity is relegated to third position, indicating that diet is the factor which explains the most variability in these obese patients. This effect is more pronounced when dietary and adipose tissue fatty acids are introduced (Table 8 ). More than 40% of variability is related to dietary habits, loaded highly by fat intake, followed by energy intake and saturated fatty acids intake. These results suggest that within the multifactorial etiology of obesity, dietary intake, especially fat intake, is the primary determinant of obesity, contrary to the recent paper that argued provocatively that`Diets high in fat do not appear to be the primary cause of the high prevalence of excess body fat in our society, and a reduction in dietary fat will not be a solution'. 42 Dietary fat has long been considered the primary dietary determinant of obesity and a logical nutrient to examine for its role in increasing prevalence of obesity. Fat is highly energy dense, extremely palatable and may also be readily stored by the body when consumed in relative excess. 43 However, the absence of weight loss after a reduction in dietary fat in some interventions, 44 and the fact that the reported percentage of dietary energy derived from fat has fallen in recent years while the prevalence of obesity continues to increase, 42 has been interpreted as suggesting that dietary fat does not play a role in the development of obesity. Several methodological problems, including the underreporting of energy and fat intake, the inadequate control for some variables such as energy expenditure and the inter-subject variation in fat intake, could limit the interpretation of these studies. 45 The present ®ndings reinforce the classical idea that dietary treatment is fundamental in obesity control. This is a cause for optimism since the diet, unlike other factors, is susceptible to modi®cation.
In conclusion, even though obesity is a multifactorial phenomenon with close and complex relationships between different factors, dietary intake, especially fat intake, still seems to be the main factor contributing to obesity, ahead of others, such as endocrine and metabolic factors. Fat intake is the main factor in obesity M Garaulet et al
Appendix 1. Total variables measured
